Allogeneic bone marrow transplantation.
From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates. With further exploration into its efficacy, allogeneic BMT will bring new challenges and opportunities for patients, families, and health care providers.
Franco
T
T
Oncology-Hematology Special Care Unit, University of Nebraska Medical Center, Omaha 68198-2405.
Gould
D A
DA
D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods*; D003131:Combined Modality Therapy; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D014184:Transplantation, Homologous